Protokinetix, Inc. 是一家处于研发阶段的生物技术公司,致力于抗衰老糖蛋白的医学科学研究。公司总部位于俄亥俄州戴尔顿。该公司于2002年1月7日上市。公司专注于抗冻糖蛋白(AFGPs)或抗衰老糖蛋白的医学科学研究。其抗衰老糖肽应用于眼科、皮肤科、器官移植支持和生物制造领域。AAGPs的商业应用包括多种医疗保健解决方案。该公司尚未开发出具有商业可行性的产品,也未产生任何收入。
PKTX stock price ended at $0.01 on 星期四, after rising 0.00%
On the latest trading day Feb 12, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.01 and a high of $0.01. Alongside this price increase, trading volume also rose by 204.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 10.0K shares were traded, amounting to a market value of approximately $3.9M.